Upcoming Events
Log In
Pricing
Free Trial

Wk 2, Case 5 - Review

HIDE
PrevNext

0:04

The last case is a melanoma case, right?

0:08

So go from the top because it's Oma.

0:12

Look at this big melanoma, right?

0:16

You guys, you guys remember the melanoma?

0:17

Melanoma has pre thickness or clark, right?

0:21

Levels, prest, low thickness,

0:24

less than one millimeter thickness.

0:26

They just like do wide local excision

0:28

and follow the, follow the melanoma up clinically, right?

0:32

One to four millimeter.

0:33

We do the sentinel node

0:35

and depending on the sentin node in the

0:37

or if it's metastatic, then they do know the dissection

0:41

and do pet for staging.

0:42

If it's not metastatic, they just close the patient

0:46

and follow the patient up, right?

0:47

They don stage it after the,

0:50

if the crystal sickness is more than four, four millimeter,

0:54

then they do know the dissection

0:56

and they send the patient for, for staging, for PET staging

0:58

because they know that this, this is a higher risk,

1:00

this patient, right?

1:02

But look at this one. This is big,

1:04

big melanoma stick melanoma.

1:06

It's even um, exo melanoma in the scap,

1:11

the frontal scap, right?

1:13

And then I'll go down

1:19

and there is metastatic lymph node,

1:23

obvious metastatic lymph node.

1:24

It's rounded, it's hypermetabolic, it's ugly,

1:29

it's an ugly, um, lymph node.

1:31

It's obviously the static lymph node, right?

1:42

This patient can progress quickly, right?

1:47

Sure. There's another file. What is it?

1:51

There's a pacemaker in this patient, right? Yeah.

1:53

And there's pacemaker, dual chamber peacemaker.

1:55

There's, and by the way, we read the, the ct.

1:59

So it's not that you read the PET

2:00

and the C for ian correction.

2:02

No, you read the, the CT

2:04

and it's a non unconscious ct,

2:05

so it's like not the easiest to read.

2:07

So we look at everything, injection site infiltration.

2:10

You look at the whole, the whole body.

2:13

One thing that is important about the melanoma patient is

2:17

you look at, it's one of the situation

2:20

where the non corrected image is important.

2:23

So, um, oh, we have a head and neck because it's a,

2:27

because it has a head and neck.

2:28

Melanoma we usually do, um, a head

2:33

and neck, a zoom neck,

2:46

just magnified more time over the head and neck.

2:50

See how much better is the

3:01

here look how much better it is.

3:05

Look, look how much better it's here.

3:07

Looking at the me side

3:10

and looking at the metastatic lymph node,

3:18

it's much better.

3:20

So we do, because it's a me of the head and neck.

3:22

We do also an extra zoom neck, which is extra position,

3:25

pet position on the head and neck.

3:28

Extended time, more time per uh, develop, uh, position

3:33

to get a better look at the head and neck.

3:35

'cause it's the primary side, right?

3:39

The other thing I was telling you is that

3:42

when it is a melanoma, what we do with

3:45

what you should do is you should, um,

3:49

pull the non corrected image.

3:53

Why? Because I'm sure, yeah,

3:57

this is the non corrected image.

3:59

How do you know it's the non corrected damage?

4:02

Because multiple things,

4:07

one of the things is that, see the, how the lung is darker

4:12

and then the skin, it's like you hold the marker

4:15

and go around the patient skin is hot, right?

4:19

This, this is not corrected damage.

4:21

So this photons coming from the skin doesn't

4:25

have any attenuation.

4:27

It makes, makes it right away to the detector.

4:29

So they are really hot, right?

4:33

Lung because it's a lot of air, no attenuation again,

4:36

so the lung are usually hot, right?

4:41

So why do I look at the non attrition

4:43

corrected in melanoma patient?

4:45

Because it exaggerate activity from the skin.

4:49

So, and melanoma sometime tends to send meds

4:54

to other side of the skin.

4:55

So I have to scan the, the whole skin carefully.

4:59

So I go slowly in the non attenuation corrected to see any,

5:03

any subtle activity that I can miss in the corrected image.

5:07

So the corrected image tweaked down the activity on the skin

5:10

because the skin activity is

5:11

exaggerated in an uncorrected image.

5:14

But here it's exaggerated.

5:16

I want it to be exaggerated

5:17

because I wanna see any sort of activity

5:19

and see if this is really something that I care about

5:22

or this is, um, just inflammation or an artifact

5:27

and I wanna mention it anyway.

5:28

So I go slowly through the whole scan

5:32

and make sure there's no sort activity that I am, i,

5:37

I didn't see in the, in the corrected image

5:41

in the melanoma case.

5:42

See? And then I come here

5:46

is the decrease the intent still,

5:48

but this is the map of the non corrected image

5:52

and I look, is there anything focal I can see on the skin?

5:56

Not really. This is just joint here.

6:01

Not really. This is the, this is the primary side.

6:04

This is the metastatic lymph node. There's nothing really.

6:08

Then I'll go back to your corrected image

6:13

and nothing else you need to see it.

6:15

So this case have the primary site

6:17

and the scalp have the metastatic lymph node,

6:19

no distant meds and nothing else to worry about.

6:24

I.

Report

Please note: Items with dashed lines (--) are information withheld as it is not relevant for you to arrive at the correct findings and impression for the report and/or it was withheld for privacy information. The items were left in to show you the typical information documented in a PET report.

Clinical Indication:
---year-old female with right frontal scalp lesion. Biopsy positive for T3b melanoma. Presenting for initial staging and treatment planning.

Technique:
Preparation: Last oral intake (except water) on ----- at -----.
Diabetic: ---.
Blood glucose at time of FDG administration: -- mg/dL.
Radiopharmaceutical: --- mCi of F-18 FDG administered IV at --- at ---.
Incubation interval: -- minutes.
Oral contrast: ---.
Positioning: Arms by sides for whole body scan and neck scan
PET/CT scanner: -------.
PET/CT acquisition: Vertex-to-feet, plus magnification (zoomed) neck.
Standardized uptake value (SUV): Corrected for ----.
CT: Low-dose, non-breath-hold, without intravenous contrast.
TOTAL DLP (Dose Length Product): ----- mGy.cm.

Comparison/Correlation:
None.

Findings:
Technical quality: Diagnostic.
Measurements: Unless otherwise specified, all SUVs refer to maximum value in the target.
Reference: mean SUV liver: ---.
CT linear measurements performed on axial images.

Head and Neck:
Intensely hypermetabolic soft tissue lesion measuring 1.2 x 1.7 cm arising from the right frontal scalp with max SUV of 8.4.
An enlarged moderately hypermetabolic right level IIB cervical lymph node measuring 1.1 cm in short axis with max SUV of 4.1.
Non-FDG avid, hypodense nodule within the right thyroid lobe measuring 1.1 cm.


Chest:
No suspicious hypermetabolic foci within the chest.
Right lower lobe granuloma.
No suspicious lung nodules.
No suspicious mediastinal or hilar adenopathy.
Right chest wall AICD with leads terminating in the right atrium and right ventricle.
Coronary artery calcifications. Aortic atherosclerosis.


Abdomen and Pelvis:
No suspicious hypermetabolic foci within the abdomen or pelvis.
No suspicious hypermetabolic retroperitoneal or pelvic adenopathy.
Distended gallbladder with cholelithiasis.
The liver, adrenal glands, and kidneys are normal in appearance.
No hydronephrosis.
Normal sized spleen with scattered granulomata.
Diffuse colonic diverticulosis.
No bowel wall thickening.
No pneumoperitoneum.
Uterus is absent.


Skeleton and Soft Tissues:
No suspicious hypermetabolic foci within the osseous structures or soft tissues.
No aggressive lytic or sclerotic lesions.
Levocurvature of the lumbar spine.
Degenerative changes throughout the spine. Old, healed left superior pubic ramus fracture.

Impression:
1. Intensely hypermetabolic soft tissue lesion arising from the right frontal scalp consistent with biopsy-proven melanoma.
2. Intensely hypermetabolic metastatic right level IIB cervical lymph node.
3. No evidence of hypermetabolic distant metastatic disease.
4. Non-FDG avid hypodense nodule in the right thyroid lobe can be further evaluated with thyroid ultrasound.

Case Discussion

Faculty

Riham El Khouli, MD

Associate Professor of Radiology, Chief, Division of Nuclear Medicine/Molecular Imaging & Radiotheranostics

University of Kentucky

Michael F. Shriver, MD

Director of Nuclear Medicine

Proscan-NCH Imaging

Tags

PET

Nuclear Medicine

CT